Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winifred Prosise

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Nature|March 8, 2018
Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysisGiovanna Scapin, Venkata P Dandey, Zhening Zhang, et al.
NPJ Microgravity|December 10, 2019
Pembrolizumab microgravity crystallization experimentationPaul Reichert, Winifred Prosise, Thierry O Fischmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine CoreTao Yu, Jayaram R Tagat, Angela D Kerekes, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 InhibitorsStéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Nature|March 8, 2018
Structure of the insulin receptor-insulin complex by single-particle cryo-EM analysisGiovanna Scapin, Venkata P Dandey, Zhening Zhang, et al.
NPJ Microgravity|December 10, 2019
Pembrolizumab microgravity crystallization experimentationPaul Reichert, Winifred Prosise, Thierry O Fischmann, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of a Potent, Injectable Inhibitor of Aurora Kinases Based on the Imidazo-[1,2-a]-Pyrazine CoreTao Yu, Jayaram R Tagat, Angela D Kerekes, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Discovery of Novel 3,3-Disubstituted Piperidines as Orally Bioavailable, Potent, and Efficacious HDM2-p53 InhibitorsStéphane L Bogen, Weidong Pan, Craig R Gibeau, et al.
Pageof 1